STOPPFrail (Screening Tool of Older Persons’ Prescriptions in Frail adults with a limited life expectancy) criteria: application to a representative population awaiting long-term nursing care
STOPPFrail criteria highlight instances of potentially inappropriate medications (PIMs) in frailer older adults with poor 1-year survival prognosis. The objectives of this study were to (i) determine the proportion of older adults requiring long-term nursing care in whom STOPPFrail criteria are applicable, (ii) measure the prevalence of STOPPFrail PIMs, and (iii) identify risk factors for PIMs in this cohort.
We retrospectively reviewed applications for long-term nursing care to nursing homes in the Cork area over a 6-month period. We recorded diagnoses, medications, functional status, cognitive ability, frailty status, and applied STOPPFrail criteria as appropriate.
We reviewed 464 applications; 38 were excluded due to incomplete information and 274 patients (64.3%) met STOPPFrail eligibility criteria (median age 83 years (IQR 77.25–88); 233 (54.7%) female). Those STOPPFrail eligible were prescribed 2194 medications (mean 8, (SD 4)), of which 828 (37.7%) were PIMs. At least one PIM was identified in 250 eligible patients (91.2%). The median number of PIMs was 3 (IQR 2–4), the most common being (i) medications without clear indication identified in 47.0% (n = 129) of patients, (ii) long-term high-dose proton pump inhibitors in 31.4% (n = 86), and (iii) statins in 29.6% (n = 81). For every additional medication prescribed, the odds of identifying a PIM increased by 58% (odds ratio 1.58, 95% CI 1.32–1.89, p < 0.001).
Almost 65% of patients awaiting long-term care are eligible for the application of STOPPFrail criteria with over 90% prescribed at least one PIM. Transition to nursing home care represents an opportunity to review therapeutic appropriateness and goals of prescribed medications.
KeywordsSTOPPFrail criteria Poor survival prognosis Potentially inappropriate medications Explicit criteria Older people
This research has been funded as part of the SENATOR project funded by the European Union’s Seventh Framework Program (EU FP7) programme (grant number 305930). Health Research Board Clinical Research Facility at University College Cork (HRB CRF-C).
Compliance with ethical standards
The local Clinical Research Ethics Committee at University College Cork (UCC) approved the study protocol.
Conflict of interest
The authors declare that they have no conflict of interest.
- 10.Harriman K, Howard L, McCracken R (2014) Deprescribing medication for frail elderly patients in nursing homes: a survey of Vancouver family physicians. B C Med J 56(9)Google Scholar
- 12.Lavan AH, Gallagher P, Parsons C, O'Mahony D (2017) STOPPFrail (Screening Tool of Older Persons Prescriptions in Frail adults with limited life expectancy): consensus validation. Age Ageing 46(4):600–607Google Scholar
- 14.The Deparment of Health, Healthy Ireland and the National Patient Safety Office. Review of the Nursing Homes Support Scheme, A Fair DealGoogle Scholar
- 15.Mahoney FI, Barthel DW (1965) Functional evaluation: the barthel index. Maryland state medical journal 14:61–65Google Scholar
- 27.Curtine D, Dukelow T, James K et al (2018) Deprescribing in multi-morbid older people with polypharmacy: agreement between STOPPFrail explicit criteria and gold standard deprescribing using 100 standardized clinical cases. Eur J Clin PharmacolGoogle Scholar
- 30.O’Connor MN, O’Sullivan D, Gallagher PF et al (2016) Prevention of hospital-acquired adverse drug reactions in older people using screening tool of older persons’ prescriptions and screening tool to alert to right treatment criteria: a cluster randomized controlled trial. J Am Geriatr Soc 64(8):1558–1566CrossRefGoogle Scholar
- 31.National Institue on Ageing and National Institutes of Health (2011) World Health Organisation: Global Health and AgeingGoogle Scholar
- 36.Executive Agency for Health and Consumers – EAHC – European Commission (2012) EU Pharmaceutical expenditure forecastGoogle Scholar